Kaleido Biosciences, Inc.
KLDO · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,272 | -$23,085 | -$23,889 | -$23,042 |
| Dep. & Amort. | $604 | $594 | $583 | $577 |
| Deferred Tax | -$120 | -$19 | $0 | $10 |
| Stock-Based Comp. | $1,705 | $2,032 | $2,376 | $4,229 |
| Change in WC | $740 | $4,429 | $680 | -$6,112 |
| Other Non-Cash | $183 | $172 | $167 | $364 |
| Operating Cash Flow | -$17,160 | -$15,877 | -$20,083 | -$23,974 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$436 | -$431 | -$232 | -$30 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $438 | $0 | $0 | $0 |
| Investing Cash Flow | $2 | -$431 | -$232 | -$30 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $69,978 |
| Stock Repurch. | -$0 | -$0 | -$104 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$25 | -$14 | -$48 | $166 |
| Financing Cash Flow | -$0 | -$0 | -$0 | $70 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17,183 | -$16,322 | -$20,383 | $46,140 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57,818 | $74,140 | $94,523 | $48,383 |
| End Cash | $40,635 | $57,818 | $74,140 | $94,523 |
| Free Cash Flow | -$17,596 | -$16,308 | -$20,315 | -$24,004 |